Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Endometrial Cancer

Americans Sit 9.5 Hours a Day. Research Links Prolonged Sitting to 24% Higher Colon Cancer Risk and 14% Higher Heart Disease Risk

Americans sit 9.5 hours/day. Research links prolonged sitting to 24% higher colon cancer, 32% endometrial cancer, and 14% CVD risk — independent of exercise. What to do about it.

Medical Daily

Karyopharm Therapeutics Spotlights Selinexor Milestones, ASCO Data and Cancer Trial Readouts

Karyopharm Therapeutics (NASDAQ:KPTI) executives used an H.C. Wainwright BioConnect Conference appearance to highlight upcoming clinical and regulatory milestones for selinexor, the company’s oral nuclear export inhibitor marketed as XPOVIO in multiple myeloma. Chief Executive Officer Richard Pauls

MarketBeat

Karyopharm Therapeutics Teases ASCO SENTRY Data as FDA Path Comes Into Focus

Karyopharm Therapeutics (NASDAQ:KPTI) executives said the company expects to provide a fuller presentation of its Phase 3 SENTRY trial data for selinexor in myelofibrosis at the upcoming ASCO conference, while also outlining expected regulatory engagement and other development priorities during a re

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Karyopharm Therapeutics Q1 Earnings Call Highlights

Karyopharm Therapeutics (NASDAQ:KPTI) said it entered 2026 with several near-term clinical and regulatory catalysts, led by new Phase 3 data in myelofibrosis and an expected midyear readout in endometrial cancer, while reporting higher first-quarter revenue and reaffirming full-year guidance. On th

MarketBeat

Why Is Genmab Stock Trading Lower On Monday?

On Saturday, Genmab A/S (NASDAQ:GMAB) revealed updated data from cohort B2 of the Phase 1/2 RAINFOL-01 trial evaluating rinatabart sesutecan (Rina-S) in heavily pretreated patients with advanced endometrial cancer.

Benzinga

Ibuprofen: how an everyday drug might offer protection against cancer

Ibuprofen is a household name – the go-to remedy for everything from headaches to period pain. But recent research suggests this everyday drug might be doing more than easing discomfort. It could also have anti-cancer properties.

The Conversation

How stripping diversity, equity and inclusion from health care may make Americans sicker

President Donald Trump’s administration has dramatically reshaped health and medical research by rolling back federal funding from institutions that have diversity, equity and inclusion initiatives and by cutting federal funding for research projects that the administration considers related to DEI.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

FDA Approves New Immunotherapy Drug For Endometrial Cancer Patients

FDA approves Jemperli for endometrial cancer, revolutionizing treatment options with immunotherapy. Keytruda and Imfinzi expand personalized therapies.

Top News

Custom-mixed hormone therapies misleading menopausal women to think personalised products are necessary, experts say

Companies are selling compounded MHT as more ‘natural’ – but there are links with endometrial cancer, the Australian Menopause Society warns

The Guardian - AU

Black patients may be missed on common cancer screening, study suggests

An early screening test for endometrial cancer may be missing the disease in many Black patients.

LiveScience

Doctors urge early checks as endometrial cancer on rise

Doctors at Brisbane's Mater hospital say higher rates of obesity among women are driving a rise in cases of endometrial cancer.

AAP

Cheaper drugs for cancer, kidney disease patients

Medicines to help women battling endometrial cancer and for people with symptoms of chronic kidney disease will be subsidised, saving patients thousands.

AAP

Vanessa Feltz claims medics told mum she was ‘neurotic’ before dying of endometrial cancer

Vanessa Feltz has claimed that her mother’s endometrial cancer was diagnosed too late due to “medical misogyny”.

Evening Standard

Mum diagnosed with cancer after she was told symptoms were due to the menopause

Beverley was diagnosed with stage three endometrial cancer last year after feeling that something wasn't right. However she said that everyone put it down to the menopause.

Edinburgh Live

Get all your
news in one place.

100's of premium titles.
One news app.

Wales Online

'I knew that something wasn’t right for years – now I have stage three cancer'

In July last year Beverley 'Bev' Hewitt from Tonypandy was diagnosed with endometrial cancer

Dynamite News

Last Rites: Farah Khan, Rashami Desai Pay Last Respect To Rakhi Sawant's Mother

The last rites of Rakhi Sawant's mother Jaya Bheda, who died due to endometrial cancer on Saturday night were performed in Oshiwara, Andheri on Sunday. Read further on Dynamite News:

ABC News

'Intelligent knife' can detect endometrial cancer in seconds

A new study has found a sophisticated tool may be able to detect and diagnose endometrial cancer in just seconds.

The Independent UK

Surgical ‘smart’ knife detects womb cancer ‘in seconds’

‘Results are highly encouraging and suggest that the iKnife could be used in the clinic to provide a point of care diagnosis’

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Surgical ‘smart’ knife detects womb cancer ‘in seconds’, study finds

‘Results are highly encouraging and suggest that the iKnife could be used in the clinic to provide a point of care diagnosis’

ABC News

Women with three children less likely to develop endometrial cancer, University of Queensland study finds

A new study finds women who have three babies are up to 50 per cent less likely to develop endometrial cancer than women who have none, due to a decreased exposure to estrogen.

Wales Online

Nurse receives urgent cancer treatment after spotting early symptom that many could ignore

"I knew the symptoms I was getting were not right. They were tiny symptoms, not very much at all."

Benzinga

Cyclacel To Test Higher Doses Of Fadraciclib In Solid Tumor Patients

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) is adding two dose levels in a protocol amendment to test higher doses of oral fadraciclib before determining the recommended Phase 2 dose anticipated in 2H of 2022, citing the absence of dose-limiting toxicities. Fifteen patients with advanced solid tumors and lymphomas were treated with oral fadraciclib at all…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Imperial College London

314 stories

Wales Online

184 stories

The National Institutes of Health

157 stories

the National Science Foundation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.